Report Type: Therapy Reports
Report Category: Blood Diseases
Report Subcategory: Acquired or Autoimmune Hemolytic Anemia
Price: 2999.00
Date: December 2021

Acquired or Autoimmune Hemolytic Anemia: Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Acquired or Autoimmune Hemolytic Anemia:
Acquired or Autoimmune Hemolytic Anemia is a blood disorder which is specified in an individual who had a normal blood (specifically RBC) system. It is a secondary disorder because this type of anemia occurs as a result of some other medical condition.

Top 10 Companies:    
Pfizer Inc
Bayer AG
Novartis AG
Merck & Co Inc
GlaxoSmithKline Plc
Sanofi
Mitsubishi Chemical Holdings Corp
AbbVie Inc
Abbott Laboratories
Takeda Pharmaceutical Co Ltd